Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 10,000 shares

Richard A Miller, Corvus Pharmaceuticals, Inc.'s President and CEO and a director of the company, recently acquired 10,000 shares of the company. The buys took place at prices ranging from $4.39 to $4.40 per share, on December 20, 2018. Miller now owns 1,108,795 shares of the company. Miller operates out of Burlingame, CA. Some additional info was provided as follows:

A portion of these shares is subject to a right of repurchase held by the Issuer.
These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

The abo ve information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh